Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124517562 | 12451756 | 2 | F | 20160707 | 20160609 | 20160715 | EXP | US-GLAXOSMITHKLINE-US2016GSK082166 | GLAXOSMITHKLINE | WIEGAND TJ, CHAMBERLIN S. TOXIN INDUCED MYOCARDIAL STUNNING WITH IMPROVEMENT IN CARDIAC CONTRACTILITY AFTER INTRAVENOUS LIPID EMULSION ADMINISTRATION. 36TH INTERNATIONAL CONGRESS OF THE EUROPEAN ASSOCIATION OF POISONS CENTRES AND C. 2016;54 (4):489 | 25.00 | YR | F | Y | 0.00000 | 20160715 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124517562 | 12451756 | 1 | PS | NICOTINE. | NICOTINE | 1 | U | 20165 | |||||||||||
| 124517562 | 12451756 | 2 | SS | CLONAZEPAM. | CLONAZEPAM | 1 | Oral | U | 0 | ||||||||||
| 124517562 | 12451756 | 3 | SS | GABAPENTIN. | GABAPENTIN | 1 | U | 0 | |||||||||||
| 124517562 | 12451756 | 4 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | U | 0 | |||||||||||
| 124517562 | 12451756 | 5 | SS | TRAZODONE HYDROCHLORIDE. | TRAZODONE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 124517562 | 12451756 | 6 | SS | HEROIN | DIACETYLMORPHINE | 1 | Oral | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124517562 | 12451756 | 1 | Product used for unknown indication |
| 124517562 | 12451756 | 2 | Product used for unknown indication |
| 124517562 | 12451756 | 3 | Product used for unknown indication |
| 124517562 | 12451756 | 4 | Product used for unknown indication |
| 124517562 | 12451756 | 5 | Product used for unknown indication |
| 124517562 | 12451756 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124517562 | 12451756 | OT |
| 124517562 | 12451756 | HO |
| 124517562 | 12451756 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124517562 | 12451756 | Body temperature decreased | |
| 124517562 | 12451756 | Cyanosis | |
| 124517562 | 12451756 | Drug screen positive | |
| 124517562 | 12451756 | Ejection fraction decreased | |
| 124517562 | 12451756 | Heart rate increased | |
| 124517562 | 12451756 | Hypoglycaemia | |
| 124517562 | 12451756 | Hypokinesia | |
| 124517562 | 12451756 | Hypotension | |
| 124517562 | 12451756 | Intentional overdose | |
| 124517562 | 12451756 | Myocardial stunning | |
| 124517562 | 12451756 | Overdose | |
| 124517562 | 12451756 | Oxygen saturation decreased | |
| 124517562 | 12451756 | Respiratory failure | |
| 124517562 | 12451756 | Rhonchi | |
| 124517562 | 12451756 | Unresponsive to stimuli |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |